Pharmacokinetics after pulmonary artery perfusion with gemcitabine

Annals of Thoracic Surgery

Volumn 76, Issue 4, 2003, Pages 1036-1040

  Van Putte, Bart P ^b   Hendriks, Jeroen M H ^a   Romijn, Sander ^b   Pauwels, Bea ^b   De Boeck, Gert ^b   Guetens, Gunther ^b   De Bruijn, Ernst ^b   Van Schil, Paul E Y ^b   Smythe, W Roy ^b   Baciewicz, Frank A ^b   Anderson, Timothy M ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; GEMCITABINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTERY PERFUSION; ARTICLE; CELL GROWTH; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; FLOW RATE; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LUNG PARENCHYMA; MALE; MAXIMUM TOLERATED DOSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY ARTERY OCCLUSION; RAT; RAT STRAIN; STATISTICAL ANALYSIS; STUDENT T TEST; TISSUE LEVEL;

ADENOCARCINOMA; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL SURVIVAL; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DEOXYCYTIDINE; LUNG; LUNG NEOPLASMS; MALE; PULMONARY CIRCULATION; RATS; RATS, INBRED STRAINS; TUMOR CELLS, CULTURED;

EID: 10744229942     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00839-7     Document Type: Article

References (26)

1. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analysis based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37-49.
2. Minchin RF, Johnston MR, Aiken MA, Boyd MR. Pharmacokinetics of doxorubicin in isolated lung of dogs and humans perfused in vivo. J Pharm Exp Ther 1984;229:193-8.
3. Osaki T, Oyama T, Takenoyama M, et al. Feasibility of induction chemotherapy using bronchial arterial infusion for locally advanced non-small cell lung cancer: a pilot study. Surg Today 2002;32:772-8.
4. Wang H-Y, Ng B, Blumberg D, Port JL, Hochwald SN, Burt ME. Pulmonary artery perfusion of doxorubicin with blood flow occlusion: pharmacokinetics and treatment in a metastatic sarcoma model. Ann Thorac Surg 1995;60:1390-4.
5. Van Putte BP, Hendriks JM, Romijn S, et al. Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival. J Surg Res 2003;109:118-22.
6. Marquet RL, Westbroek DL, Jeekel J. Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int J Cancer 1984;33:689-92.
7. Hendriks JMH, Van Schil PEY, De Boeck G, Van Oosterom A, Van Marck E, Eyskens EJM. Isolated lung perfusion with melphalan and tumor necrosis factor for pulmonary adenocarcinoma. Ann Thorac Surg 1998;66:1719-25.
8. Pestieau SR, Stuart OA, Chang D, Jacquet P, Sugarbaker PH. Pharmacokinetics of intraperitoneal gemcitabine in a rat model. Tumori 1998;84:706-11.
9. Van Moorsel CJ, Kroep JR, Pinedo HM, et al. Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors. Ann Oncol 1999;10:441-8.
10. Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-12.
11. Papazisis KT, Geromichalos GD, Dimitriadis KA, Kortsaris AH. Optimization of the sulforhodamine B colorimetric assay. J Immunol Meth 1997;208:151-8.
12. Putnam JB. New and evolving treatment methods for pulmonary metastases. Semin Thorac Cardiovasc Surg 2002;14:49-56.
13. Creech O, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 1958;148:616-32.
14. Furrer M, Lardinois D, Thormann W, et al. Isolated lung perfusion: single-pass system versus recirculating blood perfusion in pigs. Ann Thorac Surg 1998;65:1420-5.
15. Ratto GB, Esposito M, Leprini A, et al. In situ lung perfusion with cisplatin. Cancer 1993;71:2962-70.
16. Pogrebniak HW, Witt CJ, Terrill R, et al. Isolated lung perfusion with tumor necrosis factor: a swine model in preparation of human trials. Ann Thorac Surg 1994;57:1477-83.
17. Abolhoda A, Brooks A, Nawata S, Kaneda Y, Cheng H, Burt ME. Isolated lung perfusion with doxorubicin prolongs survival in a rodent model of pulmonary metastases. Ann Thorac Surg 1997;64:181-4.
18. Port JL, Ng B, Ellis JL, Nawata S, Lenert JT, Burt ME. Isolated lung perfusion with FUDR in the rat: pharmacokinetics and survival. Ann Thorac Surg 1996;62:848-52.
19. Tao-Sheng LI, Kazuro S, Kazuhiro U, Kouichi N, Sumihiko N, Kensuke E. Isolated lung perfusion with cisplatin in a rat lung solitary tumor nodule model. Anticancer Res 1998;18:4171-6.
20. Hendriks JMH, Van Schil PEY, Van Oosterom AAT, Kuppen PJK, Van Marck E, Eyskens E. Isolated lung perfusion with melphalan prolongs survival in a rat model of metastatic pulmonary adenocarcinoma. Eur Surg Res 1999;31:267-71.
21. Weksler B, Blumberg D, Lenert J, Ng B, Fong Y, Burt ME. Isolated single-lung perfusion with TNF-α in a rat sarcoma lung metastases model. Ann Thorac Surg 1994;58:328-32.
22. Johnston MR, Minchen RF, Dawson CA. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 1995;110:368-73.
23. Burt ME, Liu D, Abolhoda A, et al. Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial. Ann Thorac Surg 2000;69:1542-9.
24. Pass HI, Mew DJY, Kranda KC, Temeck BK, Donington JS, Rosenberg SA. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Ann Thorac Surg 1996;61:1609-17.
25. Ratto G, Toma S, Civalleri D, et al. Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg 1996;112:614-22.
26. Furrer M, Lardinois D, Thormann W, et al. Cytostatic lung perfusion by use of an endovascular blood flow occlusion technique. Ann Thorac Surg 1998;65:1523-8.